These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 29487069)

  • 21. Angiogenesis in Liquid Tumors: An In Vitro Assay for Leukemic-Cell-Induced Bone Marrow Angiogenesis.
    Zheng Y; Sun Y; Yu X; Shao Y; Zhang P; Dai G; Fu J
    Adv Healthc Mater; 2016 May; 5(9):1014-24. PubMed ID: 26924785
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting the leukemia microenvironment.
    Konopleva M; Andreeff M
    Curr Drug Targets; 2007 Jun; 8(6):685-701. PubMed ID: 17584025
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Normal and leukemic stem cell niches: insights and therapeutic opportunities.
    Schepers K; Campbell TB; Passegué E
    Cell Stem Cell; 2015 Mar; 16(3):254-67. PubMed ID: 25748932
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hematological malignancies: disease pathophysiology of leukemic stem cells.
    Ramdass B; Chowdhary A; Koka PS
    J Stem Cells; 2013; 8(3-4):151-87. PubMed ID: 24699024
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Remodeling of Bone Marrow Niches and Roles of Exosomes in Leukemia.
    Yamaguchi T; Kawamoto E; Gaowa A; Park EJ; Shimaoka M
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33668652
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extracellular vesicles in hematological malignancies.
    Litwińska Z; Łuczkowska K; Machaliński B
    Leuk Lymphoma; 2019 Jan; 60(1):29-36. PubMed ID: 29745272
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Histological and In Vivo Microscopic Analysis of the Bone Marrow Microenvironment in a Murine Model of Chronic Myelogenous Leukemia.
    Weissenberger ES; Krause DS
    Methods Mol Biol; 2016; 1465():59-72. PubMed ID: 27581139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Highlights: Focus on Bone Marrow Pathology.
    Ito M
    J Clin Exp Hematop; 2018; 58(2):43-44. PubMed ID: 29998974
    [No Abstract]   [Full Text] [Related]  

  • 29. MUC18, a member of the immunoglobulin superfamily, is expressed on bone marrow fibroblasts and a subset of hematological malignancies.
    Filshie RJ; Zannettino AC; Makrynikola V; Gronthos S; Henniker AJ; Bendall LJ; Gottlieb DJ; Simmons PJ; Bradstock KF
    Leukemia; 1998 Mar; 12(3):414-21. PubMed ID: 9529137
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bone Marrow Micro-Environment in Normal and Deranged Hematopoiesis: Opportunities for Regenerative Medicine and Therapies.
    Sarkaria SM; Decker M; Ding L
    Bioessays; 2018 Mar; 40(3):. PubMed ID: 29384206
    [TBL] [Abstract][Full Text] [Related]  

  • 31. "Caught in the net": the extracellular matrix of the bone marrow in normal hematopoiesis and leukemia.
    Zanetti C; Krause DS
    Exp Hematol; 2020 Sep; 89():13-25. PubMed ID: 32755619
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene Transcription as a Therapeutic Target in Leukemia.
    Khamidullina AI; Varlamova EA; Hammoud NA; Yastrebova MA; Bruter AV
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298959
    [TBL] [Abstract][Full Text] [Related]  

  • 33. WNT5A is epigenetically silenced in hematologic malignancies and inhibits leukemia cell growth as a tumor suppressor.
    Ying J; Li H; Chen YW; Srivastava G; Gao Z; Tao Q
    Blood; 2007 Dec; 110(12):4130-2. PubMed ID: 18024799
    [No Abstract]   [Full Text] [Related]  

  • 34. T cell acute lymphoblastic leukemia (T-ALL): New insights into the cellular origins and infiltration mechanisms common and unique among hematologic malignancies.
    Vadillo E; Dorantes-Acosta E; Pelayo R; Schnoor M
    Blood Rev; 2018 Jan; 32(1):36-51. PubMed ID: 28830639
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extracellular vesicle-mediated remodeling of the bone marrow microenvironment in myeloid malignancies.
    Hayashi Y; Nishimura K; Tanaka A; Inoue D
    Int J Hematol; 2023 Jun; 117(6):821-829. PubMed ID: 37041345
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Normal hematopoiesis and hematologic malignancies: role of canonical Wnt signaling pathway and stromal microenvironment.
    Seke Etet PF; Vecchio L; Bogne Kamga P; Nchiwan Nukenine E; Krampera M; Nwabo Kamdje AH
    Biochim Biophys Acta; 2013 Jan; 1835(1):1-10. PubMed ID: 22982245
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PPARγ agonists promote the resolution of myelofibrosis in preclinical models.
    Lambert J; Saliba J; Calderon C; Sii-Felice K; Salma M; Edmond V; Alvarez JC; Delord M; Marty C; Plo I; Kiladjian JJ; Soler E; Vainchenker W; Villeval JL; Rousselot P; Prost S
    J Clin Invest; 2021 Jun; 131(11):. PubMed ID: 33914703
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hematopoietic niche and bone meet.
    Frisch BJ; Porter RL; Calvi LM
    Curr Opin Support Palliat Care; 2008 Sep; 2(3):211-7. PubMed ID: 18685423
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Leukemia stem cells.
    Luo L; Han ZC
    Int J Hematol; 2006 Aug; 84(2):123-7. PubMed ID: 16926133
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The bone marrow stromal niche: a therapeutic target of hematological myeloid malignancies.
    Behrmann L; Wellbrock J; Fiedler W
    Expert Opin Ther Targets; 2020 May; 24(5):451-462. PubMed ID: 32188313
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.